Acadia Healthcare Company, Inc.
ACHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $2 |
| % Growth | 7.7% | 12.2% | 12.8% | – |
| Cost of Goods Sold | $2 | $2 | $0 | $0 |
| Gross Profit | $1 | $1 | $3 | $2 |
| % Margin | 22.6% | 23.3% | 96.2% | 96.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $2 | $1 |
| SG&A Expenses | $0 | $0 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $2 | $2 |
| Operating Income | $1 | $1 | $0 | $0 |
| % Margin | 16.6% | 17.3% | 17.9% | 17.9% |
| Other Income/Exp. Net | -$0 | -$1 | -$0 | -$0 |
| Pre-Tax Income | $0 | -$0 | $0 | $0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 8.1% | -0.7% | 10.5% | 8.2% |
| EPS | 2.79 | -0.24 | 3.05 | 2.15 |
| % Growth | 1,262.5% | -107.9% | 41.9% | – |
| EPS Diluted | 2.78 | -0.24 | 2.98 | 2.1 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $0 | $1 | $0 |
| % Margin | 19.3% | 6.5% | 21.5% | 19.9% |